Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Thoracic 12Head & Neck 2Genitourinary 1Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Breast Neoplasms 2936Neoplasms 174Lung Neoplasms 149Prostatic Neoplasms 116Ovarian Neoplasms 113Colorectal Neoplasms 106Triple Negative Breast Neoplasms 98Colonic Neoplasms 91Neoplasm Metastasis 74Melanoma 66Carcinoma, Non-Small-Cell Lung 64Pancreatic Neoplasms 63Carcinoma, Intraductal, Noninfiltrating 60Stomach Neoplasms 54Head and Neck Neoplasms 47Breast Cancer Female 45Lymphedema 42Uterine Cervical Neoplasms 40Breast Carcinoma In Situ 35Esophageal Neoplasms 34Cardiotoxicity 34Urinary Bladder Neoplasms 33Motor Activity 33Lymphoma 33Endometrial Neoplasms 33Breast Diseases 33Fatigue 30Rectal Neoplasms 28Breast Neoplasms, Male 28Multiple Myeloma 27

Interventions

Varenicline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Smoking Cessation × Breast × Clear all
NCT01532232 2015-12-23

Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)

Memorial Sloan Kettering Cancer Center

Terminated
7 enrolled
Breast

Breast Neoplasms, Tobacco Use Disorder, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡